The REPAIR (Replenishing and Enabling the Pipeline for Anti-Infective Resistance) Impact Fund invests in companies involved in discovering and early-stage development of solutions to combat antimicrobial resistance. The fund focuses on projects between lead optimization and Phase 1 clinical trials, with a goal to increase humanity's therapeutic arsenal against antimicrobial resistance.
Focus Areas
Investment Types
Notable Investments
